{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:49:58Z","timestamp":1792176598091,"version":"4.4.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Innovative Medizinische Forschung","award":["I-BI111316"],"award-info":[{"award-number":["I-BI111316"]}]},{"name":"Innovative Medizinische Forschung","award":["I-RU211405"],"award-info":[{"award-number":["I-RU211405"]}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["2105\/27-1"],"award-info":[{"award-number":["2105\/27-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.autrev.2017.12.005","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T21:18:24Z","timestamp":1520543904000},"page":"518-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Skeletal muscle cells actively shape (auto)immune responses"],"prefix":"10.1016","volume":"17","author":[{"given":"Ali Maisam","family":"Afzali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcntefering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Ruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.12.005_bb0005","first-page":"488","article-title":"\u00dcber eine eigenth\u00fcmliche Form von akuter Muskelentz\u00fcndung mit einem der Trichinose \u00e4hnelnden Krankheitsbilde","volume":"34","author":"Unverricht","year":"1887","journal-title":"M\u00fcnch Med Wochenschr"},{"key":"10.1016\/j.autrev.2017.12.005_bb0010","first-page":"282","article-title":"Fall einer seltenen Muskelkrankheit","volume":"4","author":"Wagner","year":"1863","journal-title":"Arch Heilkd"},{"key":"10.1016\/j.autrev.2017.12.005_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0140","article-title":"Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0020","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.12.005_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2005.05.003","article-title":"Immunobiology of muscle: advances in understanding an immunological microenvironment","volume":"26","author":"Wiendl","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0030","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/01.bor.0000184164.69181.ca","article-title":"Muscle-derived positive and negative regulators of the immune response","volume":"17","author":"Wiendl","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0035","doi-asserted-by":"crossref","first-page":"326437","DOI":"10.1002\/aja.1001990407","article-title":"Expression pattern of M-cadherin in normal, denervated and regenerating mouse muscles","volume":"199","author":"Irintchev","year":"1994","journal-title":"Dev Dyn"},{"key":"10.1016\/j.autrev.2017.12.005_bb0040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00002281-199411000-00004","article-title":"Cellular aspects of myositis","volume":"6","author":"Mantegazza","year":"1994","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-201x.2001.00823.x","article-title":"Immunological capabilities of skeletal muscle cells","volume":"171","author":"Nagaraju","year":"2001","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.autrev.2017.12.005_bb0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00002281-199711000-00007","article-title":"Cellular immune mechanisms in inflammatory myopathies","volume":"9","author":"Hohlfeld","year":"1997","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2017.12.005_bb0055","first-page":"478","article-title":"The NKG2D - IL- 15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies","volume":"16","author":"Ruck","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.005_bb0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"De Paepe","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0065","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.10462","article-title":"Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies","volume":"28","author":"Figarella-Branger","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.12.005_bb0070","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.autrev.2017.03.001","article-title":"Animal models in idiopathic inflammatory myopathies: how to overcome a translational roadblock?","volume":"16","author":"Afzali","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.005_bb0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"Medzhitov","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.12.005_bb0080","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.4049\/jimmunol.0903984","article-title":"Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2","volume":"184","author":"Rohrl","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0085","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e31821f440a","article-title":"Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies","volume":"76","author":"Cappelletti","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.12.005_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1753425913481820","article-title":"Human beta-defensin-3 correlates with muscle fibre degeneration in idiopathic inflammatory myopathies","volume":"20","author":"Guttsches","year":"2014","journal-title":"Innate Immun."},{"key":"10.1016\/j.autrev.2017.12.005_bb0095","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.27465","article-title":"Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines","volume":"62","author":"Tournadre","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.286.5439.525","article-title":"Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6","volume":"286","author":"Yang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.12.005_bb0105","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1128\/IAI.00286-06","article-title":"Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin","volume":"74","author":"Boyd","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2017.12.005_bb0110","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00010.2004","article-title":"Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C(2)C(12) myoblasts via Toll-like receptor-4 and c-Jun NH(2)-terminal kinase pathways","volume":"287","author":"Frost","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1096\/fj.05-4342fje","article-title":"Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands","volume":"20","author":"Schreiner","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.autrev.2017.12.005_bb0120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/art.33350","article-title":"Immature muscle precursors are a source of interferon-beta in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation","volume":"64","author":"Tournadre","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrmicro1068","article-title":"LPS, TLR4 and infectious disease diversity","volume":"3","author":"Miller","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00490.2005","article-title":"Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes","volume":"290","author":"Frost","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jns.2016.11.034","article-title":"Toll like receptor 3 and viral infections of nervous system","volume":"372","author":"Verma","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2017.12.005_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2014.10.012","article-title":"Interferons as components of the complex web of reactions sustaining inflammation in idiopathic inflammatory myopathies","volume":"74","author":"De Paepe","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2017.12.005_bb0145","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/1753425912446714","article-title":"Characterization of TLR4-mediated auto-antibody production in a mouse model of histidyl-tRNA synthetase-induced myositis","volume":"18","author":"Harlow","year":"2012","journal-title":"Innate Immun"},{"key":"10.1016\/j.autrev.2017.12.005_bb0150","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20020186","article-title":"Histidyl\u2013tRNA synthetase and asparaginyl\u2013tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells","volume":"196","author":"Howard","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.12.005_bb0155","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/art.30113","article-title":"Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis","volume":"63","author":"Soejima","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0160","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1096\/fj.09-144782","article-title":"Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies","volume":"24","author":"Grundtman","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2017.12.005_bb0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.intimp.2016.10.009","article-title":"TLR4-HMGB1 signaling pathway affects the inflammatory reaction of autoimmune myositis by regulating MHC-I","volume":"41","author":"Wan","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0170","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/annrheumdis-2012-202207","article-title":"TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis","volume":"72","author":"Zong","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.005_bb0175","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJMcibr063500","article-title":"The inflammasome\u2013a linebacker of innate defense","volume":"355","author":"Drenth","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.12.005_bb0180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.12.005_bb0185","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4103\/0366-6999.180528","article-title":"Increased expression of the NOD-like receptor family, pyrin domain containing 3 inflammasome in dermatomyositis and polymyositis is a potential contributor to their pathogenesis","volume":"129","author":"Yin","year":"2016","journal-title":"Chin Med J"},{"key":"10.1016\/j.autrev.2017.12.005_bb0190","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2353\/ajpath.2010.090058","article-title":"Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle","volume":"176","author":"Rawat","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0195","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.181.5.1863","article-title":"T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells","volume":"181","author":"Bender","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.12.005_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-5728(98)00163-5","article-title":"T cell receptor beta-chain repertoire in inclusion body myositis","volume":"91","author":"Fyhr","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0205","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.152.5.2569","article-title":"Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies","volume":"152","author":"O'Hanlon","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0210","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000265398.77681.09","article-title":"T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis","volume":"69","author":"Salajegheh","year":"2007","journal-title":"Neurology"},{"issue":"Pt 4","key":"10.1016\/j.autrev.2017.12.005_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/icb.1990.33","article-title":"Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon","volume":"68","author":"Bao","year":"1990","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0220","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4049\/jimmunol.149.2.661","article-title":"Human myoblasts as antigen-presenting cells","volume":"149","author":"Goebels","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0225","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.410230111","article-title":"Expression of immunoreactive major histocompatibility complex products in human skeletal muscles","volume":"23","author":"Karpati","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0230","first-page":"1142","article-title":"Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes","volume":"143","author":"Michaelis","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0235","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","article-title":"Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies","volume":"20","author":"Emslie-Smith","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0240","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0022-510X(89)90023-3","article-title":"Expression of class I and class II MHC antigens in neuromuscular diseases","volume":"89","author":"McDouall","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2017.12.005_bb0245","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.21103","article-title":"Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction","volume":"52","author":"Nagaraju","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0250","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.12.005_bb0255","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/art.34625","article-title":"The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy","volume":"64","author":"Coley","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065970","article-title":"Daily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositis","volume":"8","author":"Coley","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.12.005_bb0265","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ajpath.2013.06.003","article-title":"Overexpression of MHC class I in muscle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfolded protein response","volume":"183","author":"Freret","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0270","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9440(10)62513-8","article-title":"Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies","volume":"159","author":"Englund","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0275","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0165-5728(03)00093-6","article-title":"Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies","volume":"138","author":"Wiendl","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0280","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaut.2016.08.004","article-title":"The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies","volume":"75","author":"Bhattarai","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.12.005_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104048","article-title":"Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNGamma","volume":"9","author":"Ghannam","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2017.12.005_bb0290","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1074\/jbc.M110.159392","article-title":"TNF-alpha induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells","volume":"286","author":"Keller","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.12.005_bb0295","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/1531-8249(200010)48:4<679::AID-ANA19>3.0.CO;2-V","article-title":"Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G","volume":"48","author":"Wiendl","year":"2000","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.autrev.2017.12.005_bb0300","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.it.2017.01.009","article-title":"HLA-G: at the interface of maternal-fetal tolerance","volume":"38","author":"Ferreira","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0305","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.189.7.1093","article-title":"A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells","volume":"189","author":"Rajagopalan","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.12.005_bb0310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jneuroim.2009.02.005","article-title":"Intercellular exchanges of membrane fragments (trogocytosis) between human muscle cells and immune cells: a potential mechanism for the modulation of muscular immune responses","volume":"209","author":"Waschbisch","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0315","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-8674(94)90335-2","article-title":"Signals and signs for lymphocyte-responses","volume":"76","author":"Janeway","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.12.005_bb0320","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2249.1994.tb06032.x","article-title":"MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies","volume":"95","author":"Bartoccioni","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0325","first-page":"387","article-title":"Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture","volume":"140","author":"Beauchamp","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0330","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199407000-00008","article-title":"Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy","volume":"53","author":"De Bleecker","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0335","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mus.10042","article-title":"Adhesion molecule expression in experimental myositis","volume":"25","author":"Ito","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.12.005_bb0340","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-5728(02)00399-5","article-title":"TGF-beta 1 and IL-10 modulate IL-1 beta-induced membrane and soluble ICAM-1 in human myoblasts","volume":"134","author":"Marino","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0165-5728(01)00287-9","article-title":"Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts","volume":"116","author":"Marino","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0350","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2005.05.008","article-title":"Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis","volume":"5","author":"Sallum","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.005_bb0355","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/art.1780370620","article-title":"The role of cytokines in polymyositis III. Recombinant human interferon-gamma enhances T cell adhesion to cultured human muscle cells","volume":"37","author":"Kalovidouris","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2017.12.005_bb0360","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1997.tb00065.x","article-title":"Elevated soluble intercellular adhesion molecules-1 in inflammatory myopathy","volume":"95","author":"Kumamoto","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2017.12.005_bb0365","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.4049\/jimmunol.161.11.5943","article-title":"Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions","volume":"161","author":"Behrens","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0370","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0165-5728(97)00254-3","article-title":"The expression of co-stimulatory and accessory molecules on cultured human muscle cells is not dependent on stimulus by pro-inflammatory cytokines: relevance for the pathogenesis of inflammatory myopathy","volume":"85","author":"Bernasconi","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0375","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9440(10)65141-3","article-title":"Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies","volume":"155","author":"Murata","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0380","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/brain\/awh148","article-title":"Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity","volume":"127","author":"Schmidt","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.12.005_bb0385","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/awg114","article-title":"Muscle fibres and cultured muscle cells express the B7.1\/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies","volume":"126","author":"Wiendl","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.12.005_bb0390","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaut.2007.07.005","article-title":"Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation","volume":"29","author":"Katsumata","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.12.005_bb0395","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1146\/annurev.iy.12.040194.004313","article-title":"The CD40 antigen and its ligand","volume":"12","author":"Banchereau","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60865-2","article-title":"CD40-CD40 ligand: a multifunctional receptor-ligand pair","volume":"61","author":"Van Kooten","year":"1996","journal-title":"Adv Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0405","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-065X.1996.tb00921.x","article-title":"The role of CD40 ligand in costimulation and T-cell activation","volume":"153","author":"Grewal","year":"1996","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2017.12.005_bb0410","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.4049\/jimmunol.164.12.6593","article-title":"Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production","volume":"164","author":"Sugiura","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0415","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.12.005_bb0420","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1096\/fj.03-0039fje","article-title":"Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies","volume":"17","author":"Wiendl","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2017.12.005_bb0425","first-page":"154","article-title":"Expression of B7-homolog 1 in polymyositis","volume":"41","author":"Xiaoyu","year":"2011","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.autrev.2017.12.005_bb0430","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1002\/art.23997","article-title":"Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions","volume":"58","author":"Waschbisch","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0435","first-page":"275","article-title":"The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases","volume":"109","author":"Adams","year":"1997","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.autrev.2017.12.005_bb0440","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2990.1998.00092.x","article-title":"Local expression of cytokines in idiopathic inflammatory myopathies","volume":"24","author":"Lepidi","year":"1998","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0445","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-5728(95)00122-0","article-title":"Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls","volume":"63","author":"Lundberg","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0450","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0455","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005072-199603000-00009","article-title":"Cytokine expression profile in idiopathic inflammatory myopathies","volume":"55","author":"Tews","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0460","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1749-6632.1995.tb44550.x","article-title":"T-cell infiltration in polymyositis is characterized by coexpression of cytotoxic and T-cell-activating cytokine transcripts","volume":"756","author":"Andreetta","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2017.12.005_bb0465","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/intimm\/12.9.1329","article-title":"Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation","volume":"12","author":"De Rossi","year":"2000","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0470","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/clim.1999.4743","article-title":"Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells","volume":"92","author":"Nagaraju","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0475","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/rheumatology\/ket413","article-title":"Suppression of soluble T cell-associated proteins by an anti-interferon-alpha monoclonal antibody in adult patients with dermatomyositis or polymyositis","volume":"53","author":"Guo","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.12.005_bb0480","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","article-title":"A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients","volume":"73","author":"Higgs","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.005_bb0485","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.39592","article-title":"Interferon-gamma, but not interleukin-4, suppresses experimental polymyositis","volume":"68","author":"Yoshihashi-Nakazato","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0490","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/art.34465","article-title":"Interleukin-1 and tumor necrosis factor alpha blockade treatment of experimental polymyositis in mice","volume":"64","author":"Sugihara","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0495","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2139","article-title":"Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies","volume":"9","author":"Grundtman","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.12.005_bb0500","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/brain\/awn053","article-title":"Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.12.005_bb0505","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1212\/WNL.57.9.1561","article-title":"Production of IL-6 by human myoblasts stimulated with Abeta: relevance in the pathogenesis of IBM","volume":"57","author":"Baron","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.12.005_bb0510","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/intimm\/10.3.267","article-title":"Myoblasts produce IL-6 in response to inflammatory stimuli","volume":"10","author":"Gallucci","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.autrev.2017.12.005_bb0515","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/rheumatology\/ker152","article-title":"Therapeutic effect of tocilizumab on two patients with polymyositis","volume":"50","author":"Narazaki","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.12.005_bb0520","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/art.24689","article-title":"Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A","volume":"60","author":"Okiyama","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0525","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2006.03.026","article-title":"IL-6-deficient mice show impaired inflammatory response in a model of myosin-induced experimental myositis","volume":"176","author":"Scuderi","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0530","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13395-015-0058-2","article-title":"Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis","volume":"5","author":"Huang","year":"2015","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.autrev.2017.12.005_bb0535","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/annrheumdis-2011-200495","article-title":"Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor alpha expression in muscle tissue of patients with polymyositis or dermatomyositis","volume":"71","author":"Zong","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2017.12.005_bb0540","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/intimm\/dxf062","article-title":"Increased IL-15 production of muscle cells in polymyositis and dermatomyositis","volume":"14","author":"Sugiura","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0545","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gene.2016.06.055","article-title":"IL-15 up-regulates the MMP-9 expression levels and induces inflammatory infiltration of macrophages in polymyositis through regulating the NF-kB pathway","volume":"591","author":"Yan","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.autrev.2017.12.005_bb0550","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2990.2004.00591.x","article-title":"Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies","volume":"31","author":"Civatte","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0555","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/jnen\/59.2.164","article-title":"Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies","volume":"59","author":"Confalonieri","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0560","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","article-title":"Differential expression of chemokines in inflammatory myopathies","volume":"58","author":"De Bleecker","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.12.005_bb0565","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1196\/annals.1398.050","article-title":"Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses","volume":"1109","author":"De Paepe","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2017.12.005_bb0570","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/mus.20294","article-title":"Beta-chemokine receptor expression in idiopathic inflammatory myopathies","volume":"31","author":"De Paepe","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.12.005_bb0575","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00401-005-0989-5","article-title":"Alpha-chemokine receptors CXCR1\u20133 and their ligands in idiopathic inflammatory myopathies","volume":"109","author":"De Paepe","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.autrev.2017.12.005_bb0580","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s004010100394","article-title":"CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies","volume":"102","author":"Bartoli","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.autrev.2017.12.005_bb0585","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2006.06.021","article-title":"Expression of CCR7 and its ligands CCL19\/CCL21 in muscles of polymyositis","volume":"249","author":"Tateyama","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2017.12.005_bb0590","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejcb.2011.09.011","article-title":"Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target","volume":"91","author":"Crescioli","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0595","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00005072-199705000-00003","article-title":"Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate","volume":"56","author":"Confalonieri","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0600","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/NEN.0b013e3181e10925","article-title":"Macrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathies","volume":"69","author":"Reimann","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0605","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1034\/j.1600-0404.2002.1o104.x","article-title":"Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers","volume":"105","author":"Schoser","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2017.12.005_bb0610","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1212\/WNL.54.1.65","article-title":"Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies","volume":"54","author":"Choi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.12.005_bb0615","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.nbd.2006.11.008","article-title":"The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies","volume":"25","author":"Dehmel","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.autrev.2017.12.005_bb0620","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/brain\/124.2.341","article-title":"Expression of specific matrix metalloproteinases in inflammatory myopathies","volume":"124","author":"Kieseier","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.12.005_bb0625","doi-asserted-by":"crossref","first-page":"C385","DOI":"10.1152\/ajpcell.00179.2013","article-title":"Conditions that promote primary human skeletal myoblast culture and muscle differentiation in vitro","volume":"306","author":"Cheng","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0630","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1115\/1.2798040","article-title":"A tissue-like culture system using microstructures: influence of extracellular matrix material on cell adhesion and aggregation","volume":"121","author":"Knedlitschek","year":"1999","journal-title":"J Biomech Eng"},{"key":"10.1016\/j.autrev.2017.12.005_bb0635","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2017.12.005_bb0640","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00415-012-6590-7","article-title":"Targeted immunotherapy trials for idiopathic inflammatory myopathies","volume":"260","author":"Stubgen","year":"2013","journal-title":"J Neurol."},{"key":"10.1016\/j.autrev.2017.12.005_bb0645","doi-asserted-by":"crossref","first-page":"C583","DOI":"10.1152\/ajpcell.00363.2015","article-title":"The potassium channels TASK2 and TREK1 regulate functional differentiation of murine skeletal muscle cells","volume":"311","author":"Afzali","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0650","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00421-016-3411-1","article-title":"Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing","volume":"116","author":"Baumert","year":"2016","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0655","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/icb.2015.97","article-title":"Inflammation during skeletal muscle regeneration and tissue remodeling: application to exercise-induced muscle damage management","volume":"94","author":"Chazaud","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0660","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.arr.2016.03.006","article-title":"Regenerative function of immune system: modulation of muscle stem cells","volume":"27","author":"Saini","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.autrev.2017.12.005_bb0665","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.38180","article-title":"Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target","volume":"65","author":"Rayavarapu","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0670","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt.2858","article-title":"Development and function of human innate immune cells in a humanized mouse model","volume":"32","author":"Rongvaux","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0675","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0680","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized mice in translational biomedical research","volume":"7","author":"Shultz","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2017.12.005_bb0685","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/gt.2017.40","article-title":"Effect of IL-1\u03b2, TNF-\u03b1 and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle","volume":"24","author":"Gomez","year":"2017","journal-title":"Gene Ther"},{"key":"10.1016\/j.autrev.2017.12.005_bb0690","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1002\/jcp.25772","article-title":"Establishment of a new conditionally immortalized human skeletal muscle microvascular endothelial cell line","volume":"232","author":"Sano","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0695","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(95)00045-4","article-title":"Expression of cell adhesion molecules in inflammatory myopathies","volume":"59","author":"Tews","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0700","first-page":"467","article-title":"Leucocyte\/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (IIM)","volume":"104","author":"Cid","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0705","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s004010051041","article-title":"Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies","volume":"97","author":"Liprandi","year":"1999","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0710","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2169\/internalmedicine.38.632","article-title":"Expression of selectin families and their ligand sialyl Lewis X in the muscles of inflammatory myopathies: an immunohistochemical study","volume":"38","author":"Jimi","year":"1999","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2017.12.005_bb0715","doi-asserted-by":"crossref","first-page":"472624","DOI":"10.1155\/2014\/472624","article-title":"Soluble IL-2 receptor: a biomarker for assessing myositis activity","volume":"2014","author":"Tournadre","year":"2014","journal-title":"Dis Markers"},{"key":"10.1016\/j.autrev.2017.12.005_bb0720","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780330713","article-title":"Interleukin-1 alpha, interleukin-2, and soluble interleukin-2 receptors in polymyositis","volume":"33","author":"Wolf","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.005_bb0725","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/ard.51.6.781","article-title":"Soluble interleukin 2 receptors in patients with polymyositis\/dermatomyositis","volume":"51","author":"Tokano","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.005_bb0730","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","article-title":"Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis","volume":"137","author":"Chevrel","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.12.005_bb0735","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1111\/j.1365-2567.2008.03039.x","article-title":"Roles of proinflammatory cytokines and the Fas\/Fas ligand interaction in the pathogenesis of inflammatory myopathies","volume":"128","author":"Kondo","year":"2009","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.autrev.2017.12.005_bb0740","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/mus.25405","article-title":"Transforming growth factor-beta signaling is upregulated in sporadic inclusion body myositis","volume":"55","author":"Noda","year":"2017","journal-title":"Muscle Nerve"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218300557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218300557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T18:05:54Z","timestamp":1719857154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218300557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1568997218300557"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.12.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal muscle cells actively shape (auto)immune responses","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}